Recorded fact · drug.label_indication
drug.label_indication for tofacitinib|rheumatoid-arthritis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact b37cfa1c resolves to.
The record
| Fact id | b37cfa1c226b439ea56989d0 |
|---|---|
| Entity | drug: tofacitinib|rheumatoid-arthritis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:22:03.764Z |
| Source version | openfda-label-20260901 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF blockers.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 5507b3da299c9c5c8bc8bf66da775f8cdf304f3ad2f4e8cac18794c99ddab6fb.
The value
{
"ingredient": "TOFACITINIB",
"conditionId": "rheumatoid-arthritis",
"conditionName": "Rheumatoid arthritis",
"matchedAlias": "rheumatoid arthritis",
"context": "indication",
"brand": "Tofacitinib",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "253635c8-1ea7-41ba-b216-dea5e3305c47",
"labelEffectiveTime": "20260901",
"labelsRead": 13,
"labelsNaming": 10,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 2a81d359dc299c56f5ed1446e0afe394370011d862815f7380a076f296d98151.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.